Skip to Main Content
TRC_Prescriber's Letter NEW
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • GO TO CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Cardiology
  4. Ischemic Heart Disease/Acute Coronary Syndromes
  5. Prevention

Prevention

  • Angina (14)
  • Antithrombotics (419)
  • Arrhythmias (188)
  • Blood Pressure (36)
  • Cardiovascular Disease and Depression (10)
  • Cholesterol (54)
  • CPR (1)
  • Dyslipidemia (301)
  • Endocarditis (22)
  • Heart Disease (88)
  • Heart Failure (219)
  • Hypertension (344)
  • Hypotension (24)
  • Ischemic Heart Disease/Acute Coronary Syndromes (393)
    • Cardiovascular Markers (40)
    • Drug-Induced Ischemic Heart Disease (38)
    • Guidelines (4)
    • Prevention (90)
    • Treatment (298)
  • Myocardial Infarction (48)
  • Peripheral Vascular Disease (9)
  • Pulmonary Arterial Hypertension (2)
  • Raynaud's (1)
  • Resources (1022)
  • Stroke (192)
31 - 45 of 90 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Jardiance (empagliflozin) improving CV outcomes January 2017
PL Voices: Statins in Patients with Diabetes December 2016
Article: Ensure Appropriate Diabetes Patients Are on Target Statin Doses December 2016
Chart: Characteristics of the Various Statins June 2016
PL Voices: Role of Non-Statins for Dyslipidemia June 2016
Article: Don't Add Niacin or Fibrates for Most Statin Patients June 2016
Article: Talk to More Primary Prevention Patients About the Benefits and Risks of Statins May 2016
PL Voices: Role of Statins and Blood Pressure Medications in Primary Prevention of CV Disease May 2016
Commentary: BP and Lipid-Lowering Therapy in Primary Prevention: HOPE-3 May 2016
Article: Think of Durlaza as an Expensive Way to Get Low-Dose Aspirin December 2015
Commentary: New Formulation: Durlaza (Aspirin Extended-Release) December 2015
PL Voices: Cardiovascular Outcomes with Empagliflozin (Jardiance) November 2015
PL Voices: Aspirin for Primary Prevention of Cardiovascular Disease November 2015
Commentary: Empagliflozin and Cardiovascular Disease November 2015
Article: Don't be too Quick to Jump on the Jardiance (empagliflozin) Bandwagon November 2015
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved